Form 4: Guardant Health Chief Legal Officer John G. Saia Reports Stock Option and Restricted Stock Unit Awards

Guardant Health's Chief Legal Officer, John G. Saia, was granted stock options and restricted stock units on November 8, 2024, as reported in a Form 4 filing.

Summary

• John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported the acquisition of stock options and restricted stock units.
• The stock option award consists of 52,389 shares with an exercise price of $28.61, vesting over three years.
• The restricted stock unit award consists of 34,926 shares, also vesting over three years.
• Both awards were granted on November 8, 2024.
• The vesting schedule for both awards includes 33% on October 1, 2025, with the remainder vesting over the subsequent two years.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The granting of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The vesting schedule for the awards extends over three years, indicating a long-term incentive for the executive.

Industry Context

This type of equity-based compensation is common for executives in publicly traded companies, particularly in the biotech and healthcare sectors, to incentivize performance and retention.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard practice for executive compensation in the biotechnology industry.
• Companies like Exact Sciences and Illumina also use similar equity-based compensation packages for their executives.
• The vesting schedule of three years is also typical for these types of awards.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with the company's long-term performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, Form 4, insider trading, executive compensation, Guardant Health, vesting